<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//oncopeptides.io-ext.se/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://oncopeptides.io-ext.se/en/</loc>
		<lastmod>2026-04-28T15:37:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/komponenter-hero/</loc>
		<lastmod>2023-07-18T15:24:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/komponent-kolumner/</loc>
		<lastmod>2023-07-20T09:04:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/komponent-text-block/</loc>
		<lastmod>2023-07-20T11:41:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/komponent-text-media/</loc>
		<lastmod>2023-07-20T14:13:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/widgets/</loc>
		<lastmod>2023-08-09T10:19:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/komponent-kontakt/</loc>
		<lastmod>2023-08-10T12:58:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/test-english-page/</loc>
		<lastmod>2023-08-14T09:26:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/organization/</loc>
		<lastmod>2023-08-22T17:52:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/clinical-advisory-board/</loc>
		<lastmod>2023-08-22T17:52:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/our-history/a-sweden-american-journey-of-innovation-in-cancer-research/</loc>
		<lastmod>2023-08-22T17:53:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/extraordinary-general-meeting-2022/</loc>
		<lastmod>2023-08-23T11:53:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/annual-general-meeting-2021/</loc>
		<lastmod>2023-08-23T11:54:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/extraordinary-general-meeting-2020/</loc>
		<lastmod>2023-08-23T11:55:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/annual-general-meeting-2020/</loc>
		<lastmod>2023-08-23T12:35:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/the-share/insiders/</loc>
		<lastmod>2023-08-23T13:11:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/extraordinary-general-meeting-2019/</loc>
		<lastmod>2023-08-23T14:25:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/sofia-heigis-appointed-ceo-of-oncopeptides-ab/</loc>
		<lastmod>2023-08-23T15:57:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/calendar/</loc>
		<lastmod>2023-08-23T16:02:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/annual-general-meeting-2019/</loc>
		<lastmod>2023-08-23T21:52:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/extraordinary-general-meeting-2018/</loc>
		<lastmod>2023-08-24T11:22:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/annual-general-meeting-2018/</loc>
		<lastmod>2023-08-24T12:37:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/sofia-heigis-utsedd-till-vd-for-oncopeptides-ab/</loc>
		<lastmod>2023-08-24T16:37:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/annual-general-meeting-2017/</loc>
		<lastmod>2023-08-25T14:09:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/extraordinary-general-meeting-2017/</loc>
		<lastmod>2023-08-25T14:18:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/nomination-committee/</loc>
		<lastmod>2023-08-25T14:29:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/nomination-committee/past-nomination-committees/nomination-committee-2020/</loc>
		<lastmod>2023-08-25T14:59:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/nomination-committee/past-nomination-committees/nomination-committee-2019/</loc>
		<lastmod>2023-08-25T15:06:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/nomination-committee/past-nomination-committees/nomination-committee-2018/</loc>
		<lastmod>2023-08-25T15:10:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/board-committees/scientific-committee/</loc>
		<lastmod>2023-08-28T12:39:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/senior-management/</loc>
		<lastmod>2023-08-28T19:22:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/a-sweden-american-journey-of-innovation-in-cancer-research/</loc>
		<lastmod>2023-08-28T20:23:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/organisation/</loc>
		<lastmod>2023-08-28T20:57:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/extra-bolagsstamma-2022/</loc>
		<lastmod>2023-08-29T15:07:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/arsstamma-2022/</loc>
		<lastmod>2023-08-29T15:07:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/arsstamma-2021/</loc>
		<lastmod>2023-08-29T15:15:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/aktien/aktiekalkylator/</loc>
		<lastmod>2023-08-29T15:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/the-share/share-price-calculator/</loc>
		<lastmod>2023-08-29T15:33:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/extra-bolagsstamma-2020/</loc>
		<lastmod>2023-08-29T15:38:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/aktien/insynspersoner/</loc>
		<lastmod>2023-08-29T15:43:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/the-share/trading/</loc>
		<lastmod>2023-08-29T15:45:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/aktien/handel/</loc>
		<lastmod>2023-08-29T15:47:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/aktien/utdelningspolicy/</loc>
		<lastmod>2023-08-29T16:02:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/the-share/dividend-policy/</loc>
		<lastmod>2023-08-29T16:03:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/arsstamma-2020/</loc>
		<lastmod>2023-08-29T16:13:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/kalendarium/</loc>
		<lastmod>2023-08-29T16:14:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/nyemissioner/</loc>
		<lastmod>2023-08-29T16:40:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/share-issues/</loc>
		<lastmod>2023-08-29T16:41:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/extra-bolagsstamma-2019/</loc>
		<lastmod>2023-08-29T16:48:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/share-issues/share-issue-march-2021/</loc>
		<lastmod>2023-08-29T17:09:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/share-issues/share-issue-july-2022/</loc>
		<lastmod>2023-08-29T17:11:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/nyemissioner/nyemission-juli-2022/</loc>
		<lastmod>2023-08-29T17:15:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/arsstamma-2019/</loc>
		<lastmod>2023-08-29T17:21:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/share-issues/share-issue-may-2020/</loc>
		<lastmod>2023-08-29T17:30:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/nyemissioner/nyemission-maj-2020/</loc>
		<lastmod>2023-08-29T17:33:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/nyemissioner/nyemission-mars-2021/</loc>
		<lastmod>2023-08-29T17:35:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/share-issues/share-issue-june-2019/</loc>
		<lastmod>2023-08-29T17:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/nyemissioner/nyemission-juni-2019/</loc>
		<lastmod>2023-08-29T17:56:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/extra-bolagsstamma-2018/</loc>
		<lastmod>2023-08-29T17:59:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/arsstamma-2018/</loc>
		<lastmod>2023-08-29T18:28:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/arsstamma-2017/</loc>
		<lastmod>2023-08-29T18:47:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/extra-bolagsstamma-2017/</loc>
		<lastmod>2023-08-29T18:54:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/valberedning/</loc>
		<lastmod>2023-08-30T09:13:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/valberedning/tidigare-valberedningar/valberedning-2022/</loc>
		<lastmod>2023-08-30T09:27:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/valberedning/tidigare-valberedningar/valberedning-2021/</loc>
		<lastmod>2023-08-30T09:35:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/valberedning/tidigare-valberedningar/valberedning-2020/</loc>
		<lastmod>2023-08-30T09:39:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/valberedning/tidigare-valberedningar/valberedning-2019/</loc>
		<lastmod>2023-08-30T11:26:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/valberedning/tidigare-valberedningar/valberedning-2018/</loc>
		<lastmod>2023-08-30T11:29:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/styrelsens-utskott/vetenskapliga-kommitten/</loc>
		<lastmod>2023-08-30T11:58:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/intern-kontroll/</loc>
		<lastmod>2023-08-30T12:54:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/share-issues/share-issue-january-2019/</loc>
		<lastmod>2023-08-30T13:37:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/nyemissioner/nyemission-januari-2019/</loc>
		<lastmod>2023-08-30T13:55:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/share-issues/share-issue-march-2018/</loc>
		<lastmod>2023-08-30T14:30:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/nyemissioner/nyemission-mars-2018/</loc>
		<lastmod>2023-08-30T14:46:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-presentation-of-the-q2-report-2023/</loc>
		<lastmod>2023-08-31T14:38:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/dnb-healthcare-conference-2022-presentation/</loc>
		<lastmod>2023-09-01T08:46:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/dnb-healthcare-conference-2022-presentation/</loc>
		<lastmod>2023-09-01T08:47:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/fire-side-chat-at-sebs-annual-healthcare-seminar-2022/</loc>
		<lastmod>2023-09-01T08:48:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/fire-side-chat-med-vd-jakob-lindberg-pa-sebs-annual-healthcare-seminar-2022/</loc>
		<lastmod>2023-09-01T08:51:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/information-gallande-oncopeptides-overklagande-i-usa-publicerad/</loc>
		<lastmod>2023-09-01T08:51:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/information-regarding-oncopeptides-appeal-of-us-withdrawal-published/</loc>
		<lastmod>2023-09-01T08:52:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-presentation-av-rapporten-for-andra-kvartalet-2023/</loc>
		<lastmod>2023-09-01T08:53:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-genomfor-forsta-forsaljningar-av-pepaxti-i-grekland/</loc>
		<lastmod>2023-09-01T08:53:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-complete-first-sales-of-pepaxti-in-greece/</loc>
		<lastmod>2023-09-01T08:54:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-presentation-of-the-q1-interim-report-2023/</loc>
		<lastmod>2023-09-01T08:55:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-presentation-av-delarsrapporten-q1-2023/</loc>
		<lastmod>2023-09-01T08:55:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/presentation-av-bokslutskommuniken-for-2022/</loc>
		<lastmod>2023-09-01T08:56:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/presentation-of-the-year-end-report-2022/</loc>
		<lastmod>2023-09-01T08:56:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-q3-report-2022/</loc>
		<lastmod>2023-09-01T12:13:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-q3-rapporten-2022/</loc>
		<lastmod>2023-09-01T12:14:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/tyska-lanseringen-presskonferens/</loc>
		<lastmod>2023-09-01T12:15:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/german-launch-press-conference/</loc>
		<lastmod>2023-09-01T12:16:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-update-from-the-odac-meeting-sep-22/</loc>
		<lastmod>2023-09-01T12:17:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-uppdatering-fran-odac-motet-22-sep/</loc>
		<lastmod>2023-09-01T12:17:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/sustainability/responsible-governance/</loc>
		<lastmod>2023-09-01T17:14:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/hallbarhet/ansvarsfull-styrning/</loc>
		<lastmod>2023-09-01T17:17:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/privacy-policy-pharmacovigilance/</loc>
		<lastmod>2023-09-06T14:25:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/integritetspolicy-sakerhetsovervakning-for-lakemedel/</loc>
		<lastmod>2023-09-06T14:43:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/terms-of-use/</loc>
		<lastmod>2023-09-06T14:55:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/glossary/</loc>
		<lastmod>2023-09-06T15:10:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/ordlista/</loc>
		<lastmod>2023-09-06T15:16:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/stefan-norin-named-chief-medical-officer-at-oncopeptides/</loc>
		<lastmod>2023-09-07T12:27:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/test-new/</loc>
		<lastmod>2023-09-13T11:38:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/media/press-releases/</loc>
		<lastmod>2023-09-13T12:30:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/innovation/research-areas/</loc>
		<lastmod>2023-09-13T12:47:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/innovation/technology-platforms/</loc>
		<lastmod>2023-09-14T10:41:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-presentation-of-the-q2-interim-report-2022/</loc>
		<lastmod>2023-09-14T11:34:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-presentation-av-delarsrapporten-for-q2-2022/</loc>
		<lastmod>2023-09-14T11:40:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-chmp-rekommenderar-att-oncopeptides-pepaxti-far-ett-fullt-godkannande-i-eu/</loc>
		<lastmod>2023-09-14T11:53:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-hmp-rekommenderar-att-oncopeptides-pepaxti-far-ett-fullt-godkannande-i-eu/</loc>
		<lastmod>2023-09-14T11:54:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/ceo-sitdown-with-jakob-webcast-june-1-2022/</loc>
		<lastmod>2023-09-14T12:10:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/ceo-sitdown-med-jakob-webcast-1-juni-2022/</loc>
		<lastmod>2023-09-14T12:11:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/abgsc-life-science-summit-2022-presentation/</loc>
		<lastmod>2023-09-14T12:32:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/abgsc-life-science-summit-2022-presentation/</loc>
		<lastmod>2023-09-14T12:34:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-presentation-of-the-q1-interim-report-2022/</loc>
		<lastmod>2023-09-14T14:43:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-presentation-av-delarsrapporten-for-q1-2022/</loc>
		<lastmod>2023-09-14T14:46:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/carnegie-healthcare-seminar-2022/</loc>
		<lastmod>2023-09-14T14:56:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/carnegie-healthcare-seminar-2022/</loc>
		<lastmod>2023-09-14T14:57:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-presentation-av-bokslutskommuniken-2021/</loc>
		<lastmod>2023-09-14T15:14:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-presentation-of-the-year-end-report-2021/</loc>
		<lastmod>2023-09-14T15:15:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-oncopeptides-rescinds-voluntary-withdrawal-of-pepaxto/</loc>
		<lastmod>2023-09-14T15:26:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-oncopeptides-aterkallar-frivilliga-tillbakadragandet-av-pepaxto-i-usa/</loc>
		<lastmod>2023-09-14T15:33:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-presentation-of-the-q3-interim-report-2021/</loc>
		<lastmod>2023-09-14T16:03:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-presentation-av-delarsrapporten-q3-2021/</loc>
		<lastmod>2023-09-14T16:10:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/interview-with-jakob-lindberg-by-ditv-about-going-forward/</loc>
		<lastmod>2023-09-14T16:19:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/jakob-intervjuad-av-di-tv-som-ny-vd-om-att-ga-vidare/</loc>
		<lastmod>2023-09-14T16:26:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/</loc>
		<lastmod>2023-09-14T16:27:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-oncopeptides-withdraw-pepaxto-in-us-scale-down-organization-and-focus-on-rd/</loc>
		<lastmod>2023-09-14T16:33:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-oncopeptides-drar-tillbaka-pepaxto-minskar-organisationen-och-fokuserar-pa-rd/</loc>
		<lastmod>2023-09-14T16:41:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/handelsbanken-healthy-hour-presentation/</loc>
		<lastmod>2023-09-14T17:00:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/handelsbanken-healthy-hour-presentation/</loc>
		<lastmod>2023-09-14T17:02:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/board-of-directors/work-of-the-board-of-directors/work-of-the-board-of-directors/</loc>
		<lastmod>2023-09-14T17:11:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-for-presentation-of-ocean-data-presented-at-imw/</loc>
		<lastmod>2023-09-14T17:17:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-presentation-av-ocean-data-som-presenteras-pa-imw/</loc>
		<lastmod>2023-09-14T17:18:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/innovation/teknologi-plattformar/</loc>
		<lastmod>2023-09-14T17:30:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/presentation-av-delarsrapporten-q2-2021/</loc>
		<lastmod>2023-09-14T17:33:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/presentation-of-the-q2-interim-report-2021/</loc>
		<lastmod>2023-09-14T17:34:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/presentation-updated-ocean-data/</loc>
		<lastmod>2023-09-14T17:51:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/</loc>
		<lastmod>2023-09-14T18:05:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/valberedning/tidigare-valberedningar/</loc>
		<lastmod>2023-09-14T18:07:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/redeye-growth-day-2021-presentation/</loc>
		<lastmod>2023-09-14T18:09:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/redeye-growth-day-2021-presentation/</loc>
		<lastmod>2023-09-14T18:11:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/presentation-uppdaterade-ocean-resultat/</loc>
		<lastmod>2023-09-14T18:13:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/styrelsen/styrelsens-arbete/styrelsens-arbete/</loc>
		<lastmod>2023-09-14T18:14:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/presentation-of-the-q1-interim-report-2021/</loc>
		<lastmod>2023-09-14T20:40:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/presentation-av-delarsrapporten-q1-2021/</loc>
		<lastmod>2023-09-14T20:44:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-presentation-of-ocean-topline-data-may-25-2021/</loc>
		<lastmod>2023-09-14T20:54:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-presentation-av-ocean-topline-data-25-maj-2021/</loc>
		<lastmod>2023-09-14T20:59:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/theme-day-commercialization-of-medicine-erik-penser-bank/</loc>
		<lastmod>2023-09-14T21:18:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/temadag-kommersialisering-av-lakemedel-erik-penser-bank/</loc>
		<lastmod>2023-09-14T21:23:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/integritetspolicy/</loc>
		<lastmod>2023-09-14T21:33:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/aktiedagen-stockholm-aktiespararna/</loc>
		<lastmod>2023-09-14T21:34:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/aktiedagen-stockholm-aktiespararna/</loc>
		<lastmod>2023-09-14T21:35:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/personal-data/</loc>
		<lastmod>2023-09-14T21:44:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/cowen-41st-annual-health-care-conference-presentation/</loc>
		<lastmod>2023-09-14T21:45:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/cowen-41st-annual-health-care-conference-presentation/</loc>
		<lastmod>2023-09-14T21:48:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/company-presentation-march-2021/</loc>
		<lastmod>2023-09-14T21:55:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/foretagspresentation-mars-2021/</loc>
		<lastmod>2023-09-14T21:58:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-for-investors-analysts-and-the-media-fda-approval/</loc>
		<lastmod>2023-09-14T22:14:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/fda-godkannande-for-pepaxto-webcast-for-investerare-analytiker-och-media/</loc>
		<lastmod>2023-09-14T22:20:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-bokslutskommunike-2020-presentation/</loc>
		<lastmod>2023-09-14T22:31:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-year-end-report-2020-presentation/</loc>
		<lastmod>2023-09-14T22:32:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-virtual-capital-markets-day/</loc>
		<lastmod>2023-09-14T22:52:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-virtuella-kapitalmarknadsdag/</loc>
		<lastmod>2023-09-14T22:53:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/letter-from-the-ceo-annual-report-2022/</loc>
		<lastmod>2023-09-14T23:52:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vd-ord-arsredovisningen-2022/</loc>
		<lastmod>2023-09-14T23:55:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vd-ord-arsredovisningen-2021/</loc>
		<lastmod>2023-09-15T00:02:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/letter-from-the-ceo-annual-report-2021/</loc>
		<lastmod>2023-09-15T00:03:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/marty-summarizing-year-2020-video/</loc>
		<lastmod>2023-09-15T00:09:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/marty-summerar-ar-2020-video/</loc>
		<lastmod>2023-09-15T00:11:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/sustainability/social-responsibility/</loc>
		<lastmod>2023-09-15T00:13:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/hallbarhet/socialt-ansvar/</loc>
		<lastmod>2023-09-15T00:14:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/jefferies-london-health-care-conference-presentation/</loc>
		<lastmod>2023-09-15T07:46:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/jefferies-london-health-care-conference-presentation/</loc>
		<lastmod>2023-09-15T07:50:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/dnb-investor-presentation/</loc>
		<lastmod>2023-09-15T07:55:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/dnb-investerarpresentation/</loc>
		<lastmod>2023-09-15T07:59:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/citis-15th-annual-biopharma-virtual-conference-presentation/</loc>
		<lastmod>2023-09-15T08:09:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/citis-15th-annual-biopharma-virtual-conference-presentation/</loc>
		<lastmod>2023-09-15T08:12:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/pareto-securities-11e-healthcare-conference-presentation/</loc>
		<lastmod>2023-09-15T08:19:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/pareto-securities-11e-healthcare-conference-presentation/</loc>
		<lastmod>2023-09-15T08:21:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-regarding-operational-update-q2-2020/</loc>
		<lastmod>2023-09-15T08:31:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webbsandning-angaende-operationell-uppdatering-q2-2020/</loc>
		<lastmod>2023-09-15T08:35:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/nordea-small-cap-seminar-presentation/</loc>
		<lastmod>2023-09-15T08:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/nordea-small-cap-seminar-presentation/</loc>
		<lastmod>2023-09-15T08:44:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/jefferies-healthcare-conference-june-3-2020/</loc>
		<lastmod>2023-09-15T08:49:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/jefferies-healthcare-conference-3-juni-2020/</loc>
		<lastmod>2023-09-15T08:52:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-regarding-operational-update-q1-2020/</loc>
		<lastmod>2023-09-15T09:00:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/chmp-ger-positivt-besked-om-typ-ii-variation-for-att-utvidga-den-terapeutiska-indikationen-av-pepaxti-baserat-pa-resultat-av-ocean-studie/</loc>
		<lastmod>2023-09-15T09:36:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/chmp-issues-positive-opinion-on-type-ii-variation-to-extend-the-therapeutic-indication-of-pepaxti-based-on-ocean-trial-results/</loc>
		<lastmod>2023-09-15T09:44:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webbsandning-angaende-operationell-uppdatering-q1-2020/</loc>
		<lastmod>2023-09-15T09:48:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/company-presentation-april-may-2020/</loc>
		<lastmod>2023-09-15T09:53:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/foretagspresentation-april-maj-2020/</loc>
		<lastmod>2023-09-15T09:55:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/company-presentation-march-april-2020/</loc>
		<lastmod>2023-09-15T09:58:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/foretagspresentation-mars-april-2020/</loc>
		<lastmod>2023-09-15T10:00:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/stockholm-corporate-finance-life-science-day-presentation/</loc>
		<lastmod>2023-09-15T10:12:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/stockholm-corporate-finance-life-science-day-presentation/</loc>
		<lastmod>2023-09-15T10:13:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-bokslutskommuniken-2019/</loc>
		<lastmod>2023-09-15T10:21:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-year-end-report-2019/</loc>
		<lastmod>2023-09-15T10:22:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/presentation-at-seb-annual-pharma-biotech-seminar-2020/</loc>
		<lastmod>2023-09-15T10:35:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/presentation-pa-sebarliga-pharma-biotech-seminarie-2020/</loc>
		<lastmod>2023-09-15T10:35:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/2020-j-p-morgan-health-care-conference-presentation/</loc>
		<lastmod>2023-09-15T10:40:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/2020-j-p-morgan-health-care-conference-presentation/</loc>
		<lastmod>2023-09-15T10:43:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/avanza-lunch-presentation/</loc>
		<lastmod>2023-09-15T13:26:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/avanza-lunchpresentation/</loc>
		<lastmod>2023-09-15T13:30:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/investing-in-oncology-forum-2019/</loc>
		<lastmod>2023-09-15T13:40:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/investing-in-oncology-forum-2019/</loc>
		<lastmod>2023-09-15T13:41:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/foretagspresentation-3-oktober-2019/</loc>
		<lastmod>2023-09-15T14:00:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/corporate-presentation-october-2019/</loc>
		<lastmod>2023-09-15T14:01:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/pareto-health-care-conference-2019/</loc>
		<lastmod>2023-09-15T14:04:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/pareto-health-care-conference-2019/</loc>
		<lastmod>2023-09-15T14:07:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/corporate-presentation-17-june-2019/</loc>
		<lastmod>2023-09-15T14:12:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/foretagspresentation-17-juni-2019/</loc>
		<lastmod>2023-09-15T14:15:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/redeye-growth-day-presentation/</loc>
		<lastmod>2023-09-15T15:39:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/redeye-growth-day-presentation/</loc>
		<lastmod>2023-09-15T15:40:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/jefferies-2019-healthcare-conference-new-york-presentation/</loc>
		<lastmod>2023-09-15T15:52:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/jefferies-2019-healthcare-conference-new-york-presentation/</loc>
		<lastmod>2023-09-15T15:56:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/redeye-pre-asco-seminar-presentation/</loc>
		<lastmod>2023-09-15T16:09:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/redeye-pre-asco-seminar-presentation/</loc>
		<lastmod>2023-09-15T16:10:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-regarding-operational-update/</loc>
		<lastmod>2023-09-15T16:27:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-regarding-operational-update/</loc>
		<lastmod>2023-09-15T16:30:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-regarding-clinical-program-update/</loc>
		<lastmod>2023-09-15T16:35:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webbsandning-angaende-klinisk-programuppdatering/</loc>
		<lastmod>2023-09-15T16:38:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/kempen-life-science-conference-2019-presentation/</loc>
		<lastmod>2023-09-15T16:44:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/kempen-life-science-conference-2019-presentation/</loc>
		<lastmod>2023-09-15T16:49:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/cowen-company-39th-annual-health-care-conference-presentation/</loc>
		<lastmod>2023-09-15T17:01:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/cowen-company-39th-annual-health-care-conference-presentation/</loc>
		<lastmod>2023-09-15T17:02:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/carnegie-healthcare-conference-2019-presentation/</loc>
		<lastmod>2023-09-15T17:11:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/carnegie-healthcare-conference-2019-presentation/</loc>
		<lastmod>2023-09-15T17:16:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-bokslutskommuniken-2018/</loc>
		<lastmod>2023-09-15T17:28:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/seb-biotech-seminar-presentation/</loc>
		<lastmod>2023-09-15T17:34:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/seb-biotech-seminar-presentation/</loc>
		<lastmod>2023-09-15T17:38:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-year-end-report-2018/</loc>
		<lastmod>2023-09-15T17:39:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/2019-j-p-morgan-health-care-conference-presentation/</loc>
		<lastmod>2023-09-15T17:50:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/2019-j-p-morgan-health-care-conference-presentation/</loc>
		<lastmod>2023-09-15T17:51:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-capital-markets-day-in-new-york-presentations/</loc>
		<lastmod>2023-09-15T17:56:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-kapitalmarknadsdag-i-new-york-presentationer/</loc>
		<lastmod>2023-09-15T17:59:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/dnb-nordic-healthcare-conference-2018-presentation/</loc>
		<lastmod>2023-09-16T15:21:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/dnb-nordic-healthcare-conference-2018-presentation/</loc>
		<lastmod>2023-09-16T15:22:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/jakob-lindberg-ceo-oncopeptides-company-presentation-post-ash/</loc>
		<lastmod>2023-09-16T15:26:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/jakob-lindberg-vd-oncopeptides-foretagspresentation-efter-ash/</loc>
		<lastmod>2023-09-16T15:29:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/jefferies-2018-london-healthcare-conference-presentation-webcast/</loc>
		<lastmod>2023-09-16T15:34:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/jefferies-2018-london-healthcare-conference-presentation-webbsandning/</loc>
		<lastmod>2023-09-16T15:37:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/lunch-presentation-at-dnb/</loc>
		<lastmod>2023-09-16T15:41:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/lunchpresentation-hos-dnb/</loc>
		<lastmod>2023-09-16T15:42:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/jefferies-health-care-conference-new-york-presentation/</loc>
		<lastmod>2023-09-16T15:48:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/jefferies-health-care-conference-new-york-presentation/</loc>
		<lastmod>2023-09-16T15:50:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/restricted-redirect/</loc>
		<lastmod>2023-09-17T19:33:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/restricted-login/</loc>
		<lastmod>2023-09-17T19:37:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/doccheck-login-test/</loc>
		<lastmod>2023-09-17T19:48:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/career/meet-our-people/dirk-schneider/</loc>
		<lastmod>2023-09-18T08:51:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/karriar/traffa-var-personal/dirk-schneider/</loc>
		<lastmod>2023-09-18T08:53:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/finansiella-rapporter/</loc>
		<lastmod>2023-09-18T09:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/financial-reports/</loc>
		<lastmod>2023-09-18T09:23:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/jakob-lindberg-ceo-is-interviewed-in-di-tv/</loc>
		<lastmod>2023-09-18T09:51:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/jakob-lindberg-vd-intervjuas-i-di-tv/</loc>
		<lastmod>2023-09-18T09:53:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/carnegie-healthcare-seminar-2018-presentation/</loc>
		<lastmod>2023-09-18T09:57:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/carnegie-healthcare-seminar-2018-presentation/</loc>
		<lastmod>2023-09-18T10:00:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/scf-life-science-seminarium-presentation/</loc>
		<lastmod>2023-09-18T10:08:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/scf-life-science-seminarium-presentation/</loc>
		<lastmod>2023-09-18T10:09:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/abgsc-orphan-drug-day-2018-presentation/</loc>
		<lastmod>2023-09-18T10:26:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/abgsc-orphan-drug-day-2018-presentation/</loc>
		<lastmod>2023-09-18T10:27:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/innovation/</loc>
		<lastmod>2023-09-18T10:33:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/jakob-lindberg-intervjuas-i-di-borsmorgon/</loc>
		<lastmod>2023-09-18T10:35:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/jakob-lindberg-interviewed-in-di-borsmorgon/</loc>
		<lastmod>2023-09-18T10:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/jp-morgan-san-francisco-presentation/</loc>
		<lastmod>2023-09-18T10:45:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/jp-morgan-san-francisco-presentation/</loc>
		<lastmod>2023-09-18T10:47:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/dnb-nordic-healthcare-conference-2017-oslo/</loc>
		<lastmod>2023-09-18T10:56:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/carnegie-healthcare-day-in-new-york-presentation/</loc>
		<lastmod>2023-09-18T11:00:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/carnegie-healthcare-day-in-new-york-presentation/</loc>
		<lastmod>2023-09-18T11:03:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/dnb-nordic-healthcare-conference-2017-oslo/</loc>
		<lastmod>2023-09-18T11:04:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/lunch-at-abg-presentation/</loc>
		<lastmod>2023-09-18T11:08:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/abg-lunch-presentation/</loc>
		<lastmod>2023-09-18T11:13:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/pareto-securities-healthcare-conference-2017-presentation/</loc>
		<lastmod>2023-09-18T11:17:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/pareto-securities-healthcare-conference-2017-presentation/</loc>
		<lastmod>2023-09-18T11:20:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/annual-general-meeting-2017-presentation/</loc>
		<lastmod>2023-09-18T11:30:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/arsstamma-2017-presentation/</loc>
		<lastmod>2023-09-18T11:53:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/dnb-sme-conference-2017/</loc>
		<lastmod>2023-09-18T11:58:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/dnb-sme-conference-2017/</loc>
		<lastmod>2023-09-18T12:01:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/carnegie-health-care-seminariet/</loc>
		<lastmod>2023-09-18T12:06:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/carnegie-health-care-seminar/</loc>
		<lastmod>2023-09-18T12:07:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/redeye-fight-cancer-event/</loc>
		<lastmod>2023-09-18T12:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/redeye-fight-cancer-event/</loc>
		<lastmod>2023-09-18T12:15:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/</loc>
		<lastmod>2023-09-18T14:14:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/webcast-positiva-overgripande-ocean-resultat/</loc>
		<lastmod>2023-09-18T14:25:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/webcast-positive-ocean-topline-results/</loc>
		<lastmod>2023-09-18T14:26:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/post-ash-2020-webcast-presentation/</loc>
		<lastmod>2023-09-18T14:31:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/post-ash-2020-webcast-presentation/</loc>
		<lastmod>2023-09-18T14:45:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/anchor-presentation-at-ash-2020/</loc>
		<lastmod>2023-09-18T14:51:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/anchor-presentation-pa-ash-2020/</loc>
		<lastmod>2023-09-18T14:53:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/the-presentation-to-the-webcast-top-line-data-horizon/</loc>
		<lastmod>2023-09-18T15:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/presentationen-till-webcast-top-line-data-horizon/</loc>
		<lastmod>2023-09-18T15:03:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/innovation/litteraturforteckning-i-urval/</loc>
		<lastmod>2023-09-18T15:41:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/innovation/selected-bibliography/</loc>
		<lastmod>2023-09-18T15:41:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/innovation/vetenskapliga-publikationer-postrar/</loc>
		<lastmod>2023-09-18T15:45:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/innovation/scientific-publication-posters/</loc>
		<lastmod>2023-09-18T15:45:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/innovation/vetenskapliga-publikationer-postrar/horizon-op-106-postrar/</loc>
		<lastmod>2023-09-18T15:52:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/innovation/scientific-publication-posters/horizon-op-106-posters/</loc>
		<lastmod>2023-09-18T15:53:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/innovation/scientific-publication-posters/o-12-m1-posters/</loc>
		<lastmod>2023-09-18T15:56:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/innovation/vetenskapliga-publikationer-postrar/o-12-m1-postrar/</loc>
		<lastmod>2023-09-18T15:57:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/innovation/vetenskapliga-publikationer-postrar/anchor-op-104-postrar/</loc>
		<lastmod>2023-09-18T16:01:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/innovation/scientific-publication-posters/anchor-op-104-posters/</loc>
		<lastmod>2023-09-18T16:02:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/innovation/scientific-publication-posters/pre-clinical-data-posters/</loc>
		<lastmod>2023-09-18T16:05:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/innovation/vetenskapliga-publikationer-postrar/preklinisk-data-postrar/</loc>
		<lastmod>2023-09-18T16:06:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/eha-2020-posters/</loc>
		<lastmod>2023-09-18T16:19:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/eha-2020-postrar/</loc>
		<lastmod>2023-09-18T16:21:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/presentation-webcast-horizon-topline-results/</loc>
		<lastmod>2023-09-18T16:26:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/presentation-webcast-horizon-topline-resultat/</loc>
		<lastmod>2023-09-18T16:30:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/presentation-webcast-melflufens-mechanism-of-action/</loc>
		<lastmod>2023-09-18T16:39:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/presentation-webcast-melflufens-verkningsmekanism/</loc>
		<lastmod>2023-09-18T16:45:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/post-ash-webcast-2019/</loc>
		<lastmod>2023-09-18T16:56:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/post-ash-webcast-2019/</loc>
		<lastmod>2023-09-18T16:56:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/ash-2019/</loc>
		<lastmod>2023-09-18T19:32:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/ash-2019/</loc>
		<lastmod>2023-09-18T19:36:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/ash-abstracts-2019/</loc>
		<lastmod>2023-09-18T19:44:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/ash-abstrakt-2019/</loc>
		<lastmod>2023-09-18T19:46:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/lymphoma-myeloma-congress-2019/</loc>
		<lastmod>2023-09-18T19:54:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/lymphoma-myeloma-congress-2019/</loc>
		<lastmod>2023-09-18T19:56:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/european-society-for-medical-oncology-2019-esmo-27-september-2019/</loc>
		<lastmod>2023-09-18T20:03:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/european-society-for-medical-oncology-2019-esmo-september-27th-2019/</loc>
		<lastmod>2023-09-18T20:03:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/imw-2019-oral-presentation/</loc>
		<lastmod>2023-09-18T20:16:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/imw-2019-muntlig-presentation/</loc>
		<lastmod>2023-09-18T20:19:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/imw-2019-posters/</loc>
		<lastmod>2023-09-18T20:24:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/imw-2019-postrar/</loc>
		<lastmod>2023-09-18T20:26:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/society-of-hematologic-oncology-soho-2019/</loc>
		<lastmod>2023-09-18T20:33:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/society-of-hematologic-oncology-soho-2019/</loc>
		<lastmod>2023-09-18T20:36:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/eha-2019-presentations-and-articles/</loc>
		<lastmod>2023-09-18T20:57:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/eha-2019-presentationer-och-artiklar/</loc>
		<lastmod>2023-09-18T21:05:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/asco-2019-presentations-and-articles/</loc>
		<lastmod>2023-09-18T21:16:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/asco-2019-presentationer-och-artiklar/</loc>
		<lastmod>2023-09-18T21:20:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/post-eha-webcast-regarding-data-update/</loc>
		<lastmod>2023-09-18T21:26:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/eha-webcast-angaende-uppdaterad-data/</loc>
		<lastmod>2023-09-18T21:30:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/eha-2019-oral-presentation/</loc>
		<lastmod>2023-09-18T21:36:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/eha-2019-muntlig-presentation/</loc>
		<lastmod>2023-09-18T21:40:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/eha-2019-posters/</loc>
		<lastmod>2023-09-18T21:45:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/eha-2019-postrar/</loc>
		<lastmod>2023-09-18T21:49:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/2019-asco-annual-meeting-poster/</loc>
		<lastmod>2023-09-18T21:53:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/2019-asco-poster/</loc>
		<lastmod>2023-09-18T21:57:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/eha-abstracts-2019/</loc>
		<lastmod>2023-09-18T22:07:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/eha-abstrakt-2019/</loc>
		<lastmod>2023-09-18T22:14:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/asco-abstract-2019/</loc>
		<lastmod>2023-09-18T22:18:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/asco-abstrakt-2019/</loc>
		<lastmod>2023-09-18T22:24:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/aacr-2019-posters/</loc>
		<lastmod>2023-09-18T22:30:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/aacr-2019-postrar/</loc>
		<lastmod>2023-09-18T22:33:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/ash-2018-presentations-and-articles/</loc>
		<lastmod>2023-09-18T22:50:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/ash-2018-presentationer-och-artiklar/</loc>
		<lastmod>2023-09-18T22:55:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/professor-paul-g-richardson-presentation-at-ash-2018-the-horizon-study/</loc>
		<lastmod>2023-09-18T23:01:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/professor-paul-g-richardson-presentation-av-horizon-studien-pa-ash-2018/</loc>
		<lastmod>2023-09-18T23:04:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/60th-ash-annual-meeting-exposition-poster-anchor/</loc>
		<lastmod>2023-09-18T23:08:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/60th-ash-annual-meeting-exposition-poster-anchor/</loc>
		<lastmod>2023-09-18T23:10:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/ash-abstracs-2018/</loc>
		<lastmod>2023-09-18T23:18:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/ash-abstracs-2018/</loc>
		<lastmod>2023-09-18T23:19:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/presentation-at-23rd-congress-of-the-european-hematology-association-eha/</loc>
		<lastmod>2023-09-18T23:22:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/presentation-pa-det-europeiska-hematologimotet-eha/</loc>
		<lastmod>2023-09-18T23:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/ash-summary-webcast/</loc>
		<lastmod>2023-09-18T23:30:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/ash-summary-webcast/</loc>
		<lastmod>2023-09-18T23:33:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/59th-ash-annual-meeting-exposition-posters/</loc>
		<lastmod>2023-09-18T23:37:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/59th-ash-annual-meeting-exposition-posters/</loc>
		<lastmod>2023-09-18T23:40:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/scientific-presentations/american-society-of-hematology-ash-abstract/</loc>
		<lastmod>2023-09-18T23:45:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/ash-american-society-of-hematology-abstrakt/</loc>
		<lastmod>2023-09-18T23:48:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/vetenskapliga-presentationer/</loc>
		<lastmod>2023-09-18T23:51:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/cookie-declaration/</loc>
		<lastmod>2023-09-20T12:34:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-launches-oncopeptalks-with-a-fireside-chat-featuring-ceo-sofia-heigis/</loc>
		<lastmod>2023-09-20T14:17:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-lanserar-oncopeptalks-genom-ett-samtal-med-vd-sofia-heigis/</loc>
		<lastmod>2023-09-20T14:17:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/ceo-sofia-heigis-presented-to-aktiespararna-at-aktiedagen-in-stockholm/</loc>
		<lastmod>2023-09-20T14:18:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/new-information-regarding-oncopeptides-appeal-of-u-s-withdrawal-published/</loc>
		<lastmod>2023-09-21T07:57:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/vd-sofia-heigis-presenterade-for-aktiespararna-pa-aktiedagen-i-stockholm/</loc>
		<lastmod>2023-09-21T11:44:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/media/pressmeddelanden/</loc>
		<lastmod>2023-09-30T20:59:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/uppdatering-kring-oncopeptides-overklagande-av-tillbakadragande-i-usa/</loc>
		<lastmod>2023-10-03T08:29:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/update-on-oncopeptides-appeal-of-u-s-withdrawal/</loc>
		<lastmod>2023-10-03T08:41:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/career/meet-our-people/kristina-witt-mulder/</loc>
		<lastmod>2023-10-09T13:51:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/karriar/traffa-var-personal/kristina-witt-mulder/</loc>
		<lastmod>2023-10-09T13:52:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/karriar/traffa-var-personal/lina-rorby-franzen/</loc>
		<lastmod>2023-10-09T13:52:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/karriar/traffa-var-personal/lisa-andersson/</loc>
		<lastmod>2023-10-09T13:52:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/career/meet-our-people/lina-rorby-franzen/</loc>
		<lastmod>2023-10-09T13:52:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/karriar/traffa-var-personal/sofia-heigis/</loc>
		<lastmod>2023-10-09T13:55:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/career/meet-our-people/sofia-heigis/</loc>
		<lastmod>2023-10-09T13:55:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/career/meet-our-people/lisa-andersson/</loc>
		<lastmod>2023-10-09T13:55:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/career/meet-our-people/stefan-svensson-gelius/</loc>
		<lastmod>2023-10-09T13:55:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/karriar/traffa-var-personal/stefan-svensson-gelius/</loc>
		<lastmod>2023-10-09T13:56:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/karriar/traffa-var-personal/bruno-bolognese/</loc>
		<lastmod>2023-10-09T13:57:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/career/meet-our-people/bruno-bolognese/</loc>
		<lastmod>2023-10-09T13:58:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/nomination-committee/past-nomination-committees/nomination-committee-2021/</loc>
		<lastmod>2023-10-20T06:31:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/valberedning/tidigare-valberedningar/valberedning-2023/</loc>
		<lastmod>2023-10-20T06:32:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/innovation/forskningsomraden/</loc>
		<lastmod>2023-10-27T10:11:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/</loc>
		<lastmod>2023-11-01T09:47:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/</loc>
		<lastmod>2023-11-10T15:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/german-price-of-pepaxti-published/</loc>
		<lastmod>2023-11-24T10:27:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/tyska-priset-pa-pepaxti-publicerat/</loc>
		<lastmod>2023-11-24T10:29:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/oncopeptides-publishes-article-on-nk-cell-engagers-in-new-biotechnology/</loc>
		<lastmod>2023-11-24T10:38:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/oncopeptides-publicerar-artikel-om-nk-stimulerare-i-new-biotechnology/</loc>
		<lastmod>2023-11-24T10:40:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/oncopeptides-publishes-two-articles-with-results-from-anchor-and-lighthouse-studies-in-haematologica/</loc>
		<lastmod>2023-11-24T10:41:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/oncopeptides-publicerar-tva-artiklar-med-resultat-fran-studierna-anchor-och-lighthouse-i-haematologica/</loc>
		<lastmod>2023-11-24T10:45:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-announces-successful-price-negotiations-for-pepaxti-in-germany/</loc>
		<lastmod>2023-11-24T10:49:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-tillkannager-framgangsrika-prisforhandlingar-for-pepaxti-i-tyskland/</loc>
		<lastmod>2023-11-24T10:50:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/</loc>
		<lastmod>2023-11-30T08:22:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/</loc>
		<lastmod>2023-11-30T08:22:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-vd-sofia-heigis-intervjuad-i-di-healthcare/</loc>
		<lastmod>2023-11-30T10:14:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/stefan-norin-utnamnd-till-chief-medical-officer-pa-oncopeptides/</loc>
		<lastmod>2023-11-30T14:32:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/ny-information-om-oncopeptides-overklagande-i-usa-publicerad/</loc>
		<lastmod>2023-11-30T14:37:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-grundare-belonas-med-hjarnapplet/</loc>
		<lastmod>2023-12-08T10:02:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/the-founders-of-oncopeptides-awarded/</loc>
		<lastmod>2023-12-08T10:04:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/</loc>
		<lastmod>2023-12-08T10:30:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-appoints-david-augustsson-as-director-of-corporate-affairs/</loc>
		<lastmod>2023-12-13T13:53:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-utser-david-augustsson-till-chef-for-kommunikation-och-strategi/</loc>
		<lastmod>2023-12-13T13:55:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-opts-to-abandon-type-ii-variation-process-for-pepaxti-to-optimize-patient-and-shareholder-value/</loc>
		<lastmod>2023-12-15T13:59:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-valjer-att-avsluta-process-for-typ-ii-variation-for-pepaxti-i-syfte-att-optimera-patientnytta-och-aktieagarvarde/</loc>
		<lastmod>2023-12-15T14:02:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/our-history/founders/</loc>
		<lastmod>2023-12-18T11:12:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/grundare/</loc>
		<lastmod>2023-12-18T11:16:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/strategi/</loc>
		<lastmod>2023-12-20T14:30:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/strategy/</loc>
		<lastmod>2023-12-20T14:31:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/aktien/</loc>
		<lastmod>2023-12-20T15:30:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/the-share/</loc>
		<lastmod>2023-12-20T15:35:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/hallbarhet/miljoansvar/</loc>
		<lastmod>2023-12-20T15:53:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/sustainability/environmental-responsibilities/</loc>
		<lastmod>2023-12-20T15:55:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/kliniska-studier/ascent/</loc>
		<lastmod>2023-12-22T16:05:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/clinical-program/ascent/</loc>
		<lastmod>2023-12-22T16:06:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/innovation/</loc>
		<lastmod>2023-12-22T16:29:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/governance-structure/</loc>
		<lastmod>2024-01-15T15:04:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/styrningsstruktur/</loc>
		<lastmod>2024-01-15T15:04:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/oncopeptides-utvalda-att-presentera-ytterligare-data-fran-ocean-studien-vid-american-society-of-hematology-kongress/</loc>
		<lastmod>2024-01-17T14:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/oncopeptides-selected-to-present-additional-data-from-ocean-study-at-the-american-society-of-hematology-meeting/</loc>
		<lastmod>2024-01-17T14:25:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/oncopeptides-publishes-article-in-the-journal-of-clinical-pharmacology/</loc>
		<lastmod>2024-01-17T14:47:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/oncopeptides-publicerar-artikel-i-journal-of-clinical-pharmacology/</loc>
		<lastmod>2024-01-17T14:48:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/arets-sista-oncopeptalks-publicerat/</loc>
		<lastmod>2024-01-22T15:00:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/end-of-year-oncopeptalks-published/</loc>
		<lastmod>2024-01-22T15:00:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/the-q3-earnings-episode-of-oncopeptalks/</loc>
		<lastmod>2024-01-22T15:02:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/fjarde-avsnittet-av-oncopeptalks-med-kvartalsrapport-tema/</loc>
		<lastmod>2024-01-22T15:02:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/henrik-bergentoft-to-present-at-aktiespararna-sodertalje-on-january-22/</loc>
		<lastmod>2024-01-22T15:12:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/henrik-bergentoft-presenterar-pa-aktiespararna-sodertalje-den-22-januari/</loc>
		<lastmod>2024-01-22T15:13:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/sofia-heigis-presenterar-pa-redeye-fight-cancer-den-24-januari/</loc>
		<lastmod>2024-01-22T15:19:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-to-present-at-redeye-fight-cancer-on-january-24/</loc>
		<lastmod>2024-01-22T15:19:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/the-third-episode-of-oncopeptalks-industry-congresses/</loc>
		<lastmod>2024-01-22T15:20:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/tredje-avsnittet-av-oncopeptalks-medicinska-kongresser/</loc>
		<lastmod>2024-01-22T15:20:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/inget-besked-fran-fda-gallande-oncopeptides-overklagan/</loc>
		<lastmod>2024-01-22T15:21:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/no-update-from-the-fda-regarding-oncopeptides-appeal/</loc>
		<lastmod>2024-01-22T15:21:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/update-on-the-type-ii-application-process/</loc>
		<lastmod>2024-01-22T15:22:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/uppdatering-om-ansokningsprocessen-for-typ-ii/</loc>
		<lastmod>2024-01-22T15:24:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-chief-financial-officer-henrik-bergentoft-tilltrader-idag/</loc>
		<lastmod>2024-01-22T15:25:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-chief-financial-officer-henrik-bergentoft-takes-office-today/</loc>
		<lastmod>2024-01-22T15:26:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/kliniska-studier/port/</loc>
		<lastmod>2024-01-22T16:49:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/clinical-program/port/</loc>
		<lastmod>2024-01-22T16:50:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/clinical-program/lighthouse/</loc>
		<lastmod>2024-01-22T17:02:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/kliniska-studier/lighthouse/</loc>
		<lastmod>2024-01-22T17:06:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/clinical-program/o-12-m1/</loc>
		<lastmod>2024-01-23T10:52:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/clinical-program/horizon/</loc>
		<lastmod>2024-01-23T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/kliniska-studier/horizon/</loc>
		<lastmod>2024-01-23T10:54:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/kliniska-studier/o-12-m1/</loc>
		<lastmod>2024-01-23T10:55:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/kliniska-studier/ocean/</loc>
		<lastmod>2024-01-23T10:56:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/kliniska-studier/anchor/</loc>
		<lastmod>2024-01-23T10:58:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/clinical-program/anchor/</loc>
		<lastmod>2024-01-23T10:58:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/kliniska-studier/bridge/</loc>
		<lastmod>2024-01-23T11:00:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/clinical-program/bridge/</loc>
		<lastmod>2024-01-23T11:00:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/kliniska-studier/harbour/</loc>
		<lastmod>2024-01-24T15:38:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/clinical-program/harbour/</loc>
		<lastmod>2024-01-24T15:38:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/melflufen/multiple-myeloma/</loc>
		<lastmod>2024-01-30T13:14:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/melflufen/multipelt-myelom/</loc>
		<lastmod>2024-01-30T13:28:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/restricted-login-2/</loc>
		<lastmod>2024-01-30T13:52:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/restricted-redirect-2/</loc>
		<lastmod>2024-01-30T13:52:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/pipeline/intellectual-property/</loc>
		<lastmod>2024-01-30T15:49:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/pipeline/patent/</loc>
		<lastmod>2024-01-30T15:50:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/melflufen/</loc>
		<lastmod>2024-02-01T12:58:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/investigator-initiated-trials/</loc>
		<lastmod>2024-02-01T13:15:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/provarinitierade-studier/</loc>
		<lastmod>2024-02-05T10:00:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/article-with-exploratory-alkylator-refractory-subgroup-analysis-from-oncopeptides-ocean-study-observing-longer-pfs-and-os-in-melflufen-vs-pomalidomide-published-in-european-journal-of-haemat/</loc>
		<lastmod>2024-02-07T13:02:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/artikel-med-explorativ-alkylator-refraktar-subgruppsanalys-fran-oncopeptides-ocean-studie-som-observerar-langre-pfs-och-os-i-melflufen-jamfort-med-pomalidomid-publicerad-i-european-journal-of-hematolo/</loc>
		<lastmod>2024-02-07T13:02:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/product/pepaxti/</loc>
		<lastmod>2024-02-07T14:58:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/produkt/pepaxti/</loc>
		<lastmod>2024-02-07T15:01:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-ranked-among-the-top-10-companies-in-the-nordic-business-diversity-index-2024/</loc>
		<lastmod>2024-02-09T18:49:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-rankad-bland-de-10-basta-foretagen-i-nordic-business-diversity-index-2024/</loc>
		<lastmod>2024-02-09T19:00:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/</loc>
		<lastmod>2024-02-13T09:51:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/</loc>
		<lastmod>2024-02-13T09:51:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/produkt/</loc>
		<lastmod>2024-02-13T10:06:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/product/</loc>
		<lastmod>2024-02-13T10:13:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/produkt/accessprogram/</loc>
		<lastmod>2024-02-13T10:32:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/product/access-programs/</loc>
		<lastmod>2024-02-13T10:32:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/sustainability/</loc>
		<lastmod>2024-02-13T11:14:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/prospectus/</loc>
		<lastmod>2024-02-13T11:15:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/prospekt/</loc>
		<lastmod>2024-02-13T11:16:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/</loc>
		<lastmod>2024-02-14T14:14:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/hallbarhet/</loc>
		<lastmod>2024-02-14T14:16:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-investor-presentation-and-panel-at-redeye-published/</loc>
		<lastmod>2024-02-15T13:22:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-investerarpresentation-och-panel-hos-redeye-publicerad/</loc>
		<lastmod>2024-02-15T13:22:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/melflufen/</loc>
		<lastmod>2024-02-21T13:43:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/product/regulatory-status/</loc>
		<lastmod>2024-02-26T11:30:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/produkt/regulatoriskt-nulage/</loc>
		<lastmod>2024-02-26T11:32:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-om-det-senaste-fda-beslutet/</loc>
		<lastmod>2024-03-04T10:35:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/inbjudan-till-presentation-av-bokslutskommuniken-for-2023/</loc>
		<lastmod>2024-03-04T10:42:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/invitation-to-presentation-of-the-year-end-report-2023/</loc>
		<lastmod>2024-03-04T10:42:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-om-behandlingslandskap-och-konkurrens/</loc>
		<lastmod>2024-03-04T10:44:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalks-on-the-treatment-landscape-and-competition/</loc>
		<lastmod>2024-03-04T10:46:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-presenterar-pa-tva-investerartraffar/</loc>
		<lastmod>2024-03-05T09:47:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-to-present-at-two-investor-events/</loc>
		<lastmod>2024-03-05T09:49:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/vd-sofia-heigis-i-intervju-pa-ditv/</loc>
		<lastmod>2024-03-13T08:15:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/arsstamma-2023/</loc>
		<lastmod>2024-03-13T16:57:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-presented-at-stora-aktiedagarna-in-stockholm/</loc>
		<lastmod>2024-03-18T09:16:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/sofia-heigis-presenterade-pa-stora-aktiedagarna-i-stockholm/</loc>
		<lastmod>2024-03-18T09:17:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/pepaxti-bibehaller-halsorelaterad-livskvalitet-visar-ocean-studien-artikel-publicerad-i-haematologica/</loc>
		<lastmod>2024-03-18T09:17:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/pepaxti-provides-sustained-health-related-quality-of-life-ocean-study-shows-article-published-in-haematologica/</loc>
		<lastmod>2024-03-18T09:19:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/typ-ib-variationsprocess-avslutad-ursprunglig-indikation-kvarstar-med-perifer-administration-inkluderad/</loc>
		<lastmod>2024-03-18T09:19:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-tar-emot-beslut-fran-u-s-food-and-drug-administration-som-bekraftar-tillbakadragande-av-pepaxto-fran-den-amerikanska-marknaden/</loc>
		<lastmod>2024-03-18T09:20:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-receives-decision-from-the-u-s-food-and-drug-administration-confirming-withdrawal-of-pepaxto-from-the-u-s-market/</loc>
		<lastmod>2024-03-18T09:21:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-receives-positive-recommendation-for-pepaxti-by-spanish-pricing-authority/</loc>
		<lastmod>2024-03-18T09:22:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-far-positiv-rekommendation-av-pepaxti-fran-den-spanska-prismyndigheten/</loc>
		<lastmod>2024-03-18T09:22:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-sakerstaller-forlangd-marknadsexklusivitet-for-pepaxti-i-europa-med-fem-ar/</loc>
		<lastmod>2024-03-18T09:24:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-ensures-five-years-extended-market-exclusivity-for-pepaxti-in-europe/</loc>
		<lastmod>2024-03-18T09:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/oncopeptides-port-study-shows-peripheral-administration-of-pepaxti-being-equally-safe-as-central-venous-administration/</loc>
		<lastmod>2024-03-18T09:28:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/type-ib-variation-process-finalized-original-indication-remains-with-peripheral-administration-included/</loc>
		<lastmod>2024-03-18T09:29:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/</loc>
		<lastmod>2024-03-19T13:56:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/</loc>
		<lastmod>2024-03-19T13:57:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/sofia-heigis-intervjuad-av-redeyes-life-science-analytiker/</loc>
		<lastmod>2024-03-21T11:55:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/sofia-heigis-presenterar-pa-redeyes-event-commercialization-in-life-science-den-20-mars/</loc>
		<lastmod>2024-03-21T11:57:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-presents-at-redeye-commercialization-in-life-science-event-on-march-20/</loc>
		<lastmod>2024-03-21T13:35:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-vd-sofia-heigis-intervjuad-av-biostock-om-om-marknadsbearbetning-och-emission/</loc>
		<lastmod>2024-03-26T13:40:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-and-vector-pharma-fzco-announce-collaboration-to-provide-pepaxti-to-patients-in-the-middle-east-and-north-africa/</loc>
		<lastmod>2024-03-27T08:19:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-och-vector-pharma-fzco-tillkannager-samarbete-for-att-erbjuda-pepaxti-till-patienter-i-mellanostern-och-nordafrika/</loc>
		<lastmod>2024-03-27T08:19:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptalks-om-q1-forsaljning-och-mena-partnerskap/</loc>
		<lastmod>2024-04-04T06:59:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptalks-on-q1-sales-and-mena-partnership/</loc>
		<lastmod>2024-04-04T07:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-holl-investerarpresentation-for-prohearings/</loc>
		<lastmod>2024-04-11T09:35:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-held-investor-presentation-at-prohearings/</loc>
		<lastmod>2024-04-11T09:35:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-participated-at-invest-in-oncology-forum/</loc>
		<lastmod>2024-04-11T09:48:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-deltog-pa-invest-in-oncology-forum/</loc>
		<lastmod>2024-04-11T09:49:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-med-i-penserpodden/</loc>
		<lastmod>2024-04-12T12:33:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-sakerstaller-nationell-subvention-for-pepaxti-i-spanien/</loc>
		<lastmod>2024-04-15T12:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-secures-national-reimbursement-for-pepaxti-in-spain/</loc>
		<lastmod>2024-04-15T12:19:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/disclaimer/</loc>
		<lastmod>2024-04-17T08:27:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/ansvarsfriskrivning/</loc>
		<lastmod>2024-04-17T08:31:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/disclaimer-oncopeptides-carries-out-rights-issue/</loc>
		<lastmod>2024-04-17T08:55:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/ansvarsfriskrivning-oncopeptides-genomfor-foretradesemission/</loc>
		<lastmod>2024-04-17T08:57:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/ansvarsfriskrivning-foretradesemission-maj-2024/</loc>
		<lastmod>2024-04-17T09:05:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/disclaimer-rights-issue-2024/</loc>
		<lastmod>2024-04-17T09:07:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/fortydligande-angaende-beslut-fran-nice/</loc>
		<lastmod>2024-04-25T11:10:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/oncopeptides-port-studie-visar-att-perifer-venos-administrering-av-pepaxti-ar-lika-saker-som-central-venos-administrering/</loc>
		<lastmod>2024-04-25T11:12:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/clarification-regarding-recent-decision-from-nice/</loc>
		<lastmod>2024-04-25T11:33:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalks-featuring-cristina-bando-spanish-country-manager/</loc>
		<lastmod>2024-04-25T13:31:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-med-cristina-bando-country-manager-i-spanien/</loc>
		<lastmod>2024-04-25T13:32:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-participates-in-the-marketmakers-podcast/</loc>
		<lastmod>2024-04-25T15:33:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-med-i-podden-marketmakers/</loc>
		<lastmod>2024-04-25T15:33:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/annual-general-meeting-2023/</loc>
		<lastmod>2024-04-29T13:37:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/annual-general-meeting-2023/annual-general-meeting-2023-filmed-qa-session/</loc>
		<lastmod>2024-04-29T13:38:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/arsstamma-2023/arsstamma-2023-inspelad-fragestund/</loc>
		<lastmod>2024-04-29T13:39:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/extra-bolagsstamma-2024/</loc>
		<lastmod>2024-04-29T13:39:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/extraordinary-general-meeting-2024/</loc>
		<lastmod>2024-04-29T13:40:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/share-issues/rights-issue-may-2024-1/</loc>
		<lastmod>2024-05-06T20:00:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-genomfor-foretradesemission-1/</loc>
		<lastmod>2024-05-07T11:28:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-carries-out-rights-issue-1/</loc>
		<lastmod>2024-05-07T11:30:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/kontakt/visselblasning/</loc>
		<lastmod>2024-05-07T12:33:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/contact/whistleblowing/</loc>
		<lastmod>2024-05-07T12:35:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/kontakt/medicinsk-information/</loc>
		<lastmod>2024-05-15T09:40:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/contact/medical-information/</loc>
		<lastmod>2024-05-15T09:40:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/kontakt/anlaggningar/</loc>
		<lastmod>2024-05-15T11:32:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/contact/facilities/</loc>
		<lastmod>2024-05-15T11:32:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/oncopeptides-presenterar-nya-data-som-belyser-behandlingsfordelarna-med-pepaxti-i-hogriskpatienter-med-multipelt-myelom-vid-comy-kongressen/</loc>
		<lastmod>2024-05-16T07:28:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/oncopeptides-presents-new-data-highlighting-treatment-benefits-of-pepaxti-in-high-risk-multiple-myeloma-patients-at-the-comy-congress/</loc>
		<lastmod>2024-05-16T07:28:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-launches-spanish-website/</loc>
		<lastmod>2024-05-16T07:31:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-lanserar-spansk-hemsida/</loc>
		<lastmod>2024-05-16T07:32:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-om-spanien-besok-och-nyemission/</loc>
		<lastmod>2024-05-22T14:25:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalks-on-spain-visit-and-rights-issue/</loc>
		<lastmod>2024-05-22T14:25:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/de-forsta-patienterna-i-spanien-behandlas-snart-med-pepaxti/</loc>
		<lastmod>2024-05-27T08:53:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/about-cookies/</loc>
		<lastmod>2024-05-29T14:46:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/om-cookies/</loc>
		<lastmod>2024-05-29T14:50:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/invitation-to-presentation-of-the-q1-report-2024/</loc>
		<lastmod>2024-05-30T08:13:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/inbjudan-till-presentation-av-rapporten-for-forsta-kvartalet-2024/</loc>
		<lastmod>2024-05-30T08:14:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-interviewed-at-redeye-growth-day/</loc>
		<lastmod>2024-06-04T14:56:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/sofia-heigis-intervjuad-pa-redye-growth-day/</loc>
		<lastmod>2024-06-04T14:57:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/first-patients-in-spain-to-be-treated-with-pepaxti/</loc>
		<lastmod>2024-06-05T11:27:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/ceo-presentation-from-recent-annual-general-meeting/</loc>
		<lastmod>2024-06-05T12:12:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/vd-presentation-fran-arsstamman-2024/</loc>
		<lastmod>2024-06-05T13:08:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-holl-investerarpresentation-for-aktiespararna/</loc>
		<lastmod>2024-06-12T14:10:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/var-historia/</loc>
		<lastmod>2024-06-26T10:06:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/</loc>
		<lastmod>2024-06-26T10:09:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/our-journey-updated-version/</loc>
		<lastmod>2024-06-27T11:27:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/our-journey-uppdaterad-version/</loc>
		<lastmod>2024-06-27T11:27:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/</loc>
		<lastmod>2024-06-27T12:15:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-om-kongresser-och-cd-val/</loc>
		<lastmod>2024-06-27T14:44:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalks-on-congresses-and-cd-selection/</loc>
		<lastmod>2024-06-27T14:45:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/oncopeptides-utser-forsta-lakemedelskandidaten-fran-sin-spike-plattform/</loc>
		<lastmod>2024-06-28T10:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/oncopeptides-selects-first-candidate-drug-from-its-spike-platform/</loc>
		<lastmod>2024-06-28T10:29:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/pipeline/spike-platform/</loc>
		<lastmod>2024-07-03T11:20:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/pipeline/spike-plattform/</loc>
		<lastmod>2024-07-03T11:21:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/pipeline/</loc>
		<lastmod>2024-07-03T11:31:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/pipeline/</loc>
		<lastmod>2024-07-03T11:36:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/pipeline/pdc-platform/</loc>
		<lastmod>2024-07-03T11:36:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/pipeline/pdc-plattform/</loc>
		<lastmod>2024-07-03T11:37:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/inbjudan-till-presentation-av-rapporten-for-andra-kvartalet-2024/</loc>
		<lastmod>2024-08-14T07:02:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/invitation-to-presentation-of-the-q2-report-2024/</loc>
		<lastmod>2024-08-14T07:02:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-presented-at-aktiespararna-event/</loc>
		<lastmod>2024-08-29T07:07:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-holl-investerarpresentation-for-aktiespararna-temakvall-life-science/</loc>
		<lastmod>2024-08-30T08:12:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-presented-at-aktiespararna-event-theme-life-science/</loc>
		<lastmod>2024-08-30T08:12:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-expands-woda-partnership-with-addition-of-africa-and-eurasia/</loc>
		<lastmod>2024-09-04T12:05:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-utokar-woda-samarbete-till-afrika-och-eurasien/</loc>
		<lastmod>2024-09-04T12:07:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/lotta-larsson-ny-hr-chef-pa-oncopeptides/</loc>
		<lastmod>2024-09-09T21:15:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/lotta-larsson-joins-oncopeptides-as-new-head-of-human-resources/</loc>
		<lastmod>2024-09-09T21:15:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalks-on-south-korea-growth-and-pipeline/</loc>
		<lastmod>2024-09-12T11:02:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-om-sydkorea-tillvaxt-och-pipeline/</loc>
		<lastmod>2024-09-12T11:02:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-tecknar-licensavtal-med-scbio-for-pepaxti-i-sydkorea/</loc>
		<lastmod>2024-09-12T11:22:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-signs-license-agreement-with-scbio-for-pepaxti-in-south-korea/</loc>
		<lastmod>2024-09-12T11:22:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/recognizing-the-european-multiple-myeloma-day/</loc>
		<lastmod>2024-09-23T14:54:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/vi-uppmarksammar-den-europeiska-myelom-dagen/</loc>
		<lastmod>2024-09-23T14:55:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/sofia-traffar-patrick-jordan-som-ar-pa-besok-i-stockholm-for-att-bland-annat-diskutera-partnerskapet-mellan-organisationerna-vem-som-gor-vad-i-samarbetet-samt-tidsplanen-for-forsaljning-david-och/</loc>
		<lastmod>2024-10-11T13:56:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptalks-with-special-guest-patrick-jordan-chairman-of-the-world-orphan-drug-alliance/</loc>
		<lastmod>2024-10-11T13:58:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalks-on-the-recent-fda-decision/</loc>
		<lastmod>2024-10-15T15:31:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/invitation-to-presentation-of-the-q3-report-2024/</loc>
		<lastmod>2024-11-07T09:01:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/inbjudan-till-presentation-av-rapporten-for-tredje-kvartalet-2024/</loc>
		<lastmod>2024-11-07T09:01:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-interviewed-by-redeye/</loc>
		<lastmod>2024-11-12T09:04:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalks-addressing-your-q3-questions/</loc>
		<lastmod>2024-11-12T15:02:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-svar-pa-dina-fragor-om-q3/</loc>
		<lastmod>2024-11-12T15:02:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/oncopeptides-invited-to-present-at-ash-in-december/</loc>
		<lastmod>2024-11-20T07:31:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/oncopeptides-inbjudna-att-presentera-pa-ash-i-december/</loc>
		<lastmod>2024-11-20T07:31:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/sofia-heigis-presenterade-pa-biostock-life-science-summit/</loc>
		<lastmod>2024-11-25T08:56:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-presented-at-biostock-life-science-summit/</loc>
		<lastmod>2024-11-25T09:07:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptalks-on-reimbursement-in-italy/</loc>
		<lastmod>2024-11-27T16:55:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptalks-om-subvention-i-italien/</loc>
		<lastmod>2024-11-27T16:57:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-obtains-reimbursement-for-pepaxti-in-italy/</loc>
		<lastmod>2024-11-27T17:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-erhaller-subvention-for-pepaxti-i-italien/</loc>
		<lastmod>2024-11-27T17:05:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-presented-at-stora-aktiedagarna/</loc>
		<lastmod>2024-11-28T12:51:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/sofia-heigis-presenterade-pa-stora-aktiedagarna/</loc>
		<lastmod>2024-11-28T12:52:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptalks-meet-the-italian-team/</loc>
		<lastmod>2024-12-04T09:48:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptalks-mot-det-italienska-teamet/</loc>
		<lastmod>2024-12-04T09:48:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-participated-at-redeye-life-science-event/</loc>
		<lastmod>2024-12-05T17:15:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-deltog-vid-redye-life-science-event/</loc>
		<lastmod>2024-12-05T17:15:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-lanserar-italiensk-hemsida/</loc>
		<lastmod>2024-12-09T12:54:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-launches-italian-website/</loc>
		<lastmod>2024-12-09T12:55:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptalks-2024-in-review/</loc>
		<lastmod>2024-12-20T11:41:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptalks-sammanfattning-av-2024/</loc>
		<lastmod>2024-12-20T11:43:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-interviewed-by-redeyes-life-science-analyst/</loc>
		<lastmod>2025-01-22T09:22:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptalks-looking-into-2025/</loc>
		<lastmod>2025-01-23T09:03:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptalks-en-blick-in-i-2025/</loc>
		<lastmod>2025-01-23T09:03:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-presented-at-redeye-fight-cancer-on-january-22-2025/</loc>
		<lastmod>2025-01-24T08:47:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/sofia-heigis-presenterade-vid-redeye-fight-cancer-den-22-januari-2025/</loc>
		<lastmod>2025-01-24T08:48:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-pepaxti-formally-approved-for-full-reimbursement-in-italy/</loc>
		<lastmod>2025-01-27T09:02:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-pepaxti-formellt-godkant-for-full-subvention-i-italien/</loc>
		<lastmod>2025-01-27T09:03:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-presented-at-aktiespararna-life-science-2025/</loc>
		<lastmod>2025-01-30T15:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/auditors/</loc>
		<lastmod>2025-02-03T15:30:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/revisorer/</loc>
		<lastmod>2025-02-03T15:32:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/kommentar-till-uppmarksamhet-i-media/</loc>
		<lastmod>2025-02-04T13:58:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/regarding-recent-media-attention/</loc>
		<lastmod>2025-02-04T13:58:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/strong-real-world-efficacy-and-safety-data-with-pepaxti-published-in-the-european-journal-of-haematology/</loc>
		<lastmod>2025-02-25T07:35:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/starka-real-world-data-kring-effekt-och-sakerhet-for-pepaxti-publicerade-i-european-journal-of-haematology/</loc>
		<lastmod>2025-02-25T07:35:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/inbjudan-till-presentation-av-bokslutskommuniken-for-2024/</loc>
		<lastmod>2025-02-27T08:01:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/invitation-to-presentation-of-the-year-end-report-2024/</loc>
		<lastmod>2025-02-27T08:01:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/sofia-heigis-intervjuad-av-redeye/</loc>
		<lastmod>2025-02-28T13:24:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/vd-sofia-heigis-intervjuad-av-redeye/</loc>
		<lastmod>2025-02-28T13:53:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/ceo-sofia-heigis-interviewed-by-redeye/</loc>
		<lastmod>2025-02-28T14:17:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/our-history/</loc>
		<lastmod>2025-03-06T14:34:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/career/career-opportunities/</loc>
		<lastmod>2025-03-10T16:29:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/karriar/jobba-hos-oss/</loc>
		<lastmod>2025-03-10T16:29:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/tidigare-bolagsstammor/arsstamma-2024/</loc>
		<lastmod>2025-03-11T09:07:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/annual-general-meeting-2024/</loc>
		<lastmod>2025-03-11T09:07:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptides-receives-first-order-of-pepaxti-in-italy/</loc>
		<lastmod>2025-03-11T12:33:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptides-erhaller-sin-forsta-bestallning-av-pepaxti-i-italien/</loc>
		<lastmod>2025-03-11T12:33:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsordning/</loc>
		<lastmod>2025-03-11T16:08:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/articles-of-association/</loc>
		<lastmod>2025-03-11T16:10:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-presenterade-pa-stora-aktiedagarna-stockholm/</loc>
		<lastmod>2025-03-12T09:56:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-presented-at-stora-aktiedagarna-stockholm/</loc>
		<lastmod>2025-03-12T10:04:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/oncopeptalks-first-order-in-italy-and-q4-report/</loc>
		<lastmod>2025-03-13T16:18:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/oncopeptalks-forsta-ordern-i-italien-och-q4-rapport/</loc>
		<lastmod>2025-03-13T16:18:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-presenterade-vid-redeye-eventet-commercialization-in-life-science/</loc>
		<lastmod>2025-03-21T15:45:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-presented-at-the-redeye-event-commercialization-in-life-science/</loc>
		<lastmod>2025-03-21T15:45:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/clinical-program/clinical-development/</loc>
		<lastmod>2025-03-24T14:31:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/kliniska-studier/klinisk-utveckling/</loc>
		<lastmod>2025-03-24T14:32:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/career/meet-our-people/</loc>
		<lastmod>2025-03-26T13:35:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/karriar/traffa-var-personal/</loc>
		<lastmod>2025-03-26T13:37:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/symposia-esh-order-information-links/</loc>
		<lastmod>2025-03-27T13:19:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/fda-removes-clinical-hold-of-oncopeptides-pipeline-drug-opd5/</loc>
		<lastmod>2025-04-01T06:30:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/fda-haver-kliniskt-stopp-for-oncopeptides-pipeline-lakemedel-opd5/</loc>
		<lastmod>2025-04-01T06:30:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-en-mix-av-amnen/</loc>
		<lastmod>2025-04-11T13:54:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalks-a-mixed-bag-of-topics/</loc>
		<lastmod>2025-04-11T13:54:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/company-news/notice-to-annual-general-meeting-at-oncopeptides-ab-publ/</loc>
		<lastmod>2025-04-16T06:41:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/foretagsnyheter/kallelse-till-arsstamma-i-oncopeptides-ab-publ/</loc>
		<lastmod>2025-04-16T06:42:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstyrningsrapporter/</loc>
		<lastmod>2025-04-28T15:40:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/corporate-governance-reports/</loc>
		<lastmod>2025-04-28T15:41:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/remuneration/remuneration-reports/</loc>
		<lastmod>2025-04-28T15:42:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/ersattning/ersattningsrapporter/</loc>
		<lastmod>2025-04-28T15:43:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/nya-real-world-data-starker-evidensen-for-pepaxtis-effekt-och-tolerabilitet-hos-patienter-med-multipelt-myelom/</loc>
		<lastmod>2025-05-09T15:21:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/new-real-world-data-support-effectiveness-and-tolerability-of-pepaxti-in-heavily-pretreated-multiple-myeloma-patients/</loc>
		<lastmod>2025-05-09T15:23:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/invitation-to-presentation-of-the-q1-report-2025/</loc>
		<lastmod>2025-05-15T07:02:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/inbjudan-till-presentation-av-rapporten-for-forsta-kvartalet-2025/</loc>
		<lastmod>2025-05-15T07:02:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/vd-sofia-heigis-intervjuad-av-redeye-2/</loc>
		<lastmod>2025-05-16T09:14:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-interviewed-by-redeye-2/</loc>
		<lastmod>2025-05-16T09:14:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalks-q1-and-comy/</loc>
		<lastmod>2025-05-16T12:55:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-q1-och-comy/</loc>
		<lastmod>2025-05-16T12:55:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/kliniska-studier/</loc>
		<lastmod>2025-05-19T11:58:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/clinical-program/</loc>
		<lastmod>2025-05-19T11:59:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/forsta-patienten-studie-for-inhamtande-av-real-world-data-i-tyskland-rekryterad/</loc>
		<lastmod>2025-05-20T12:40:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/first-patient-enters-real-world-data-study-in-germany/</loc>
		<lastmod>2025-05-20T12:41:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/oncopeptides-inleder-ny-real-world-studie-av-pepaxti-i-spanien-forsta-patienten-rekryterad/</loc>
		<lastmod>2025-05-20T13:01:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/oncopeptides-launches-new-real-world-evidence-study-of-pepaxti-in-spain-first-patient-enrolled/</loc>
		<lastmod>2025-05-20T13:02:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/board-committees/</loc>
		<lastmod>2025-05-26T12:59:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/styrelsens-utskott/</loc>
		<lastmod>2025-05-26T13:02:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/media/image-bank/</loc>
		<lastmod>2025-05-26T13:04:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/media/bildbank/</loc>
		<lastmod>2025-05-26T13:06:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/the-share/analysts/</loc>
		<lastmod>2025-05-26T13:22:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/aktien/analytiker/</loc>
		<lastmod>2025-05-26T13:24:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-presents-at-biostock-global-forum-2025/</loc>
		<lastmod>2025-05-26T14:22:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-presenterar-pa-biostock-global-forum-2025/</loc>
		<lastmod>2025-05-26T14:25:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/kliniska-studier/lagoon/</loc>
		<lastmod>2025-06-05T11:32:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/clinical-program/lagoon/</loc>
		<lastmod>2025-06-05T11:37:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/clinical-program/ocean/</loc>
		<lastmod>2025-06-05T11:38:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/hallbarhet/policies/</loc>
		<lastmod>2025-06-05T12:48:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/sustainability/policies/</loc>
		<lastmod>2025-06-05T12:48:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/annual-general-meeting-2025/</loc>
		<lastmod>2025-06-10T15:48:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/arsstamma-2025/</loc>
		<lastmod>2025-06-10T15:52:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-presented-at-the-aktiespararna-event-aktiedagarna/</loc>
		<lastmod>2025-06-10T16:04:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-holl-investerarpresentation-for-aktiespararna-under-aktiedagarna/</loc>
		<lastmod>2025-06-10T16:09:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/privacy-notice/</loc>
		<lastmod>2025-06-23T16:06:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalks-the-first-half-of-2025-and-a-look-into-the-future/</loc>
		<lastmod>2025-07-04T09:41:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-forsta-halvaret-2025-och-en-blick-framat/</loc>
		<lastmod>2025-07-04T09:41:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/pepaxti-inkluderas-i-europeiska-riktlinjer-for-behandling-av-multipelt-myelom/</loc>
		<lastmod>2025-07-08T08:28:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/pepaxti-included-in-european-guidelines-for-the-treatment-of-multiple-myeloma/</loc>
		<lastmod>2025-07-08T08:28:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-announces-net-sales-for-q2-2025/</loc>
		<lastmod>2025-07-09T13:36:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-offentliggor-forsaljning-for-andra-kvartalet-2025/</loc>
		<lastmod>2025-07-09T13:39:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/sofia-heigis-intervjuad-av-redeye-2/</loc>
		<lastmod>2025-07-14T23:27:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-interviewed-by-redeye-3/</loc>
		<lastmod>2025-07-14T23:36:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/the-trinity-concept/</loc>
		<lastmod>2025-07-26T12:52:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/trinity-konceptet/</loc>
		<lastmod>2025-07-26T12:58:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/oncopeptides-announces-acceptance-of-spanish-and-italian-real-world-data-at-ims-annual-meeting/</loc>
		<lastmod>2025-08-14T14:58:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/oncopeptides-meddelar-att-spansk-och-italiensk-real-world-data-accepterats-till-ims/</loc>
		<lastmod>2025-08-14T15:01:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-ingar-partnerskap-med-sd-pharma-for-att-ytterligare-starka-pepaxtis-rackvidd-i-spanien/</loc>
		<lastmod>2025-08-14T15:07:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-partners-with-sd-pharma-to-further-broaden-pepaxti-reach-in-spain/</loc>
		<lastmod>2025-08-14T15:08:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/nyemissioner/foretradesemission-maj-2024-1/</loc>
		<lastmod>2025-08-21T05:41:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/invitation-to-presentation-of-the-q2-report-2025/</loc>
		<lastmod>2025-08-21T07:09:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/inbjudan-till-presentation-av-rapporten-for-andra-kvartalet-2025/</loc>
		<lastmod>2025-08-21T12:33:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/kultur-varderingar/</loc>
		<lastmod>2025-08-22T07:48:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/culture-values/</loc>
		<lastmod>2025-08-22T07:49:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-relations-contacts/</loc>
		<lastmod>2025-08-22T07:54:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerarkontakter/</loc>
		<lastmod>2025-08-22T07:54:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/media/media-contact/</loc>
		<lastmod>2025-08-22T07:58:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/media/mediekontakt/</loc>
		<lastmod>2025-08-22T07:59:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/new-real-world-data-confirms-efficacy-and-safety-of-pepaxti/</loc>
		<lastmod>2025-09-01T08:01:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/ny-real-world-data-bekraftar-effektivitet-och-sakerhet-hos-pepaxti/</loc>
		<lastmod>2025-09-01T08:06:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/vind-i-seglen-for-oncopeptides-emission-ska-sakerstalla-fortsatt-kommersiellt-momentum/</loc>
		<lastmod>2025-09-05T07:14:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/biostock-investor-pitch-oncopeptides/</loc>
		<lastmod>2025-09-09T14:01:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/biostock-investor-pitch-oncopeptides/</loc>
		<lastmod>2025-09-09T14:02:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/ceo-sofia-heigis-in-an-interview-with-biostock/</loc>
		<lastmod>2025-09-12T09:18:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/vd-sofia-heigis-i-intervju-med-biostock/</loc>
		<lastmod>2025-09-12T09:19:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/ceo-sofia-heigis-presented-at-aktiespararna/</loc>
		<lastmod>2025-09-16T12:39:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/vd-sofia-heigis-holl-investerarpresentation-under-aktiedagarna-hos-aktiespararna/</loc>
		<lastmod>2025-09-16T12:44:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/nyemissioner/foretradesemission-2025/</loc>
		<lastmod>2025-09-17T06:50:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/share-issues/rights-issue-2025/</loc>
		<lastmod>2025-09-17T06:58:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalk-about-rights-issue-europe-and-ims/</loc>
		<lastmod>2025-09-17T07:36:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-om-emissionen-europa-och-ims/</loc>
		<lastmod>2025-09-17T07:37:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/vd-sofia-heigis-intervjuad-av-redeye-3/</loc>
		<lastmod>2025-09-17T07:39:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/ceo-sofia-heigis-interviewed-by-redeye-2/</loc>
		<lastmod>2025-09-17T07:40:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/investor-qa-oncopeptides-rights-issue-and-japan-partnership/</loc>
		<lastmod>2025-09-17T07:41:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/fragor-och-svar-for-investerare-foretradesemission-och-partnerskap-i-japan/</loc>
		<lastmod>2025-09-17T07:43:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/congresses/</loc>
		<lastmod>2025-09-30T07:04:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/kongresser/</loc>
		<lastmod>2025-09-30T07:06:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-deltog-pa-biostock-investing-in-life-science/</loc>
		<lastmod>2025-10-01T13:43:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-participated-at-biostock-investing-in-life-science/</loc>
		<lastmod>2025-10-01T13:44:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/kontakt/</loc>
		<lastmod>2025-10-06T07:42:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/media/</loc>
		<lastmod>2025-10-06T07:47:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/media/</loc>
		<lastmod>2025-10-06T07:48:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/owner-list-mfn-genererad-lista/</loc>
		<lastmod>2025-10-06T09:29:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/aktieagare-mfn-genererad-lista/</loc>
		<lastmod>2025-10-06T09:31:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/melflufen/mechanism-of-action/</loc>
		<lastmod>2025-10-06T12:17:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/exceptional-long-term-responses-to-pepaxti-new-publication-in-journal-of-cancer-research-and-clinical-oncology/</loc>
		<lastmod>2025-10-16T12:29:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/exceptionell-respons-pa-langtidsbehandling-med-pepaxti-ny-publikation-i-journal-of-cancer-research-and-clinical-oncology/</loc>
		<lastmod>2025-10-16T12:29:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/melflufen/verkningsmekanism/</loc>
		<lastmod>2025-10-16T15:16:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/board-of-directors/work-of-the-board-of-directors/</loc>
		<lastmod>2025-11-03T13:17:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/styrelsen/styrelsens-arbete/</loc>
		<lastmod>2025-11-03T13:18:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/forskning-fran-ledande-universitet-tillsammans-med-oncopeptides-kring-nk-cellengagerare-presenteras-pa-ash/</loc>
		<lastmod>2025-11-03T14:33:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/research-by-top-universities-together-with-oncopeptides-on-nk-cell-engagers-to-be-presented-at-ash/</loc>
		<lastmod>2025-11-03T14:34:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/</loc>
		<lastmod>2025-11-04T21:56:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/</loc>
		<lastmod>2025-11-04T21:57:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/invitation-to-presentation-of-the-q3-report-2025/</loc>
		<lastmod>2025-11-05T08:01:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/inbjudan-till-presentation-av-rapporten-for-tredje-kvartalet-2025/</loc>
		<lastmod>2025-11-05T08:01:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/ceo-sofia-heigis-interviewed-by-redeye-3/</loc>
		<lastmod>2025-11-05T13:09:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/vd-sofia-heigis-intervjuad-av-redeye-4/</loc>
		<lastmod>2025-11-05T13:10:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/annals-of-hematology-experter-stodjer-anvandande-av-pepaxti-mot-myelom/</loc>
		<lastmod>2025-11-11T07:31:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/annals-of-hematology-expert-consensus-supports-use-of-pepaxti-in-myeloma/</loc>
		<lastmod>2025-11-11T07:31:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/nkengage-grant-projektet-slutfort/</loc>
		<lastmod>2025-11-12T12:36:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/nkengage-grant-project-completed/</loc>
		<lastmod>2025-11-12T12:38:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/career/</loc>
		<lastmod>2025-11-13T14:22:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/karriar/</loc>
		<lastmod>2025-11-13T14:23:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/nomination-committee/past-nomination-committees/nomination-committee-2024/</loc>
		<lastmod>2025-11-21T09:07:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/valberedning/tidigare-valberedningar/valberedning-2024/</loc>
		<lastmod>2025-11-21T09:07:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/nomination-committee/past-nomination-committees/</loc>
		<lastmod>2025-11-21T09:08:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/nomination-committee/nomination-committee-2026/</loc>
		<lastmod>2025-11-21T09:11:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/valberedning/valberedning-2026/</loc>
		<lastmod>2025-11-21T09:14:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/valberedning/tidigare-valberedningar/valberedning-2025/</loc>
		<lastmod>2025-11-21T09:18:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/nomination-committee/past-nomination-committees/nomination-committee-2025/</loc>
		<lastmod>2025-11-21T09:20:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-holl-investerarpresentation-pa-aktiespararnas-temakvall-life-science/</loc>
		<lastmod>2025-11-27T10:01:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-presenterade-pa-stora-aktiedagarna-ett-aktiespararna-event-i-stockholm/</loc>
		<lastmod>2025-11-27T10:02:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-presented-at-stora-aktiedagarna-a-aktiespararna-event-in-stockholm/</loc>
		<lastmod>2025-11-27T10:57:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-to-host-capital-markets-update-november-13/</loc>
		<lastmod>2025-12-09T12:36:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-anordnar-till-capital-markets-update-13-november/</loc>
		<lastmod>2025-12-09T12:39:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-kommersialisering-pipeline-och-ash/</loc>
		<lastmod>2025-12-16T15:56:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalks-commercialization-pipeline-and-ash/</loc>
		<lastmod>2025-12-16T15:56:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/forskning-visar-att-pepaxti-ar-effektivt-vid-hogriskmyelom/</loc>
		<lastmod>2025-12-31T10:34:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/research-shows-that-pepaxti-is-effective-in-high-risk-myeloma/</loc>
		<lastmod>2025-12-31T10:34:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/webcast-in-conjunction-to-oncopeptides-announces-q4-2025-sales-and-updates-cash-flow-expectations/</loc>
		<lastmod>2026-01-16T09:06:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/webcast-i-samband-med-offentliggorande-av-omsattning-for-fjarde-kvartalet-2025/</loc>
		<lastmod>2026-01-16T09:07:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/ceo-sofia-heigis-interviewed-by-redeye-4/</loc>
		<lastmod>2026-01-19T16:54:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/inbjudan-till-presentation-av-bokslutskommuniken-for-2025/</loc>
		<lastmod>2026-02-19T09:01:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/invitation-to-presentation-of-the-year-end-report-2025/</loc>
		<lastmod>2026-02-19T09:03:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/contact/</loc>
		<lastmod>2026-02-19T12:56:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/vd-sofia-heigis-intervjuad-av-redeye-5/</loc>
		<lastmod>2026-02-20T08:33:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptides-vd-sofia-heigis-intervjuad-av-redeye-om-q4-och-nyemissionen/</loc>
		<lastmod>2026-02-20T08:42:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptides-ceo-sofia-heigis-interviewed-by-redeye-about-q4-and-the-new-share-issue/</loc>
		<lastmod>2026-02-20T08:42:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-om-q4-rapporten-2025-nyemission-och-nyheter-i-pipeline/</loc>
		<lastmod>2026-02-23T17:24:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalks-about-the-q4-report-2025-rights-issue-and-news-about-the-pipeline/</loc>
		<lastmod>2026-02-23T17:49:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/oncopeptides-vaxlar-upp-emission-ska-ta-bolaget-till-positivt-kassaflode-2027/</loc>
		<lastmod>2026-02-26T15:57:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/remuneration/</loc>
		<lastmod>2026-03-03T09:16:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/ersattning/</loc>
		<lastmod>2026-03-03T09:17:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/internal-control/</loc>
		<lastmod>2026-03-03T14:57:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/nomination-committee/past-nomination-committees/nomination-committee-2023/</loc>
		<lastmod>2026-03-04T13:38:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/nomination-committee/past-nomination-committees/nomination-committee-2022/</loc>
		<lastmod>2026-03-04T13:41:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/</loc>
		<lastmod>2026-03-05T09:42:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/oncopeptides-secures-fast-track-designation-for-window-of-opportunity-study-in-glioblastoma/</loc>
		<lastmod>2026-03-09T07:35:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/oncopeptides-erhaller-fast-track-status-for-window-of-opportunity-studie-i-glioblastom/</loc>
		<lastmod>2026-03-09T07:35:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/past-general-meetings/annual-general-meeting-2022/</loc>
		<lastmod>2026-03-10T15:17:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/ceo-sofia-heigis-presents-oncopeptides-at-aktiespararna/</loc>
		<lastmod>2026-03-11T12:30:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/vd-sofia-heigis-presenterar-oncopeptides-hos-aktiespararna/</loc>
		<lastmod>2026-03-11T12:31:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-presents-at-biostock/</loc>
		<lastmod>2026-03-11T13:26:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/sofia-heigis-presenterar-pa-biostock/</loc>
		<lastmod>2026-03-11T13:26:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/european-journal-of-haematology-real-world-data-reinforces-pepaxtis-role-in-treatment-sequencing-for-multiple-myeloma/</loc>
		<lastmod>2026-03-13T10:09:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/european-journal-of-haematology-real-world-data-starker-pepaxtis-roll-i-behandlingssekvensen-vid-multipelt-myelom/</loc>
		<lastmod>2026-03-13T10:11:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/oncopeptides-initiates-marina-study-to-strengthen-real-world-evidence-for-pepaxti-in-germany/</loc>
		<lastmod>2026-03-16T08:31:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/oncopeptides-initierar-studie-for-att-starka-real-world-evidens-for-pepaxti-i-tyskland/</loc>
		<lastmod>2026-03-16T08:31:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/nyemissioner/foretradesemission-2026/</loc>
		<lastmod>2026-03-18T08:36:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/share-issues/rights-issue-2026/</loc>
		<lastmod>2026-03-18T08:56:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/oncopeptalks-om-real-world-data-och-fragor-fran-investerare/</loc>
		<lastmod>2026-03-20T13:53:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/oncopeptalks-on-real-world-data-and-questions-from-investors/</loc>
		<lastmod>2026-03-20T13:55:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/oncopeptalks/</loc>
		<lastmod>2026-03-20T14:03:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/oncopeptalks/</loc>
		<lastmod>2026-03-20T14:05:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/sofia-heigis-presented-and-interviewed-at-stockholm-corporate-finance-life-science-days/</loc>
		<lastmod>2026-03-20T14:53:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/sofia-heigis-presenterade-och-intervjuades-pa-stockholm-corporate-finance-life-science-dagar/</loc>
		<lastmod>2026-03-20T14:58:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/investerar-presentationer/vd-sofia-heigis-presenterade-vid-redeye-eventet-commercialization-in-life-science/</loc>
		<lastmod>2026-03-23T10:29:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/investor-presentations/ceo-sofia-heigis-presented-at-redeye-event-commercialization-in-life-science/</loc>
		<lastmod>2026-03-23T10:29:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/aktien/aktiekapitalets-utveckling/</loc>
		<lastmod>2026-03-31T08:50:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/the-share/share-capital-development/</loc>
		<lastmod>2026-03-31T08:53:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/investerare/aktien/aktieagare/</loc>
		<lastmod>2026-04-10T17:44:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/science/science-news/preclinical-data-on-novel-nk-cell-engager-to-be-presented-at-the-aacr-annual-meeting-2026/</loc>
		<lastmod>2026-04-13T11:33:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/forskning/forskningsnyheter/prekliniska-data-for-ny-nk-cellsengagerare-presenteras-vid-aacrs-arsmote-2026/</loc>
		<lastmod>2026-04-13T11:37:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/styrelsen/</loc>
		<lastmod>2026-04-14T09:03:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/board-of-directors/</loc>
		<lastmod>2026-04-14T09:03:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/leadership/</loc>
		<lastmod>2026-04-14T09:11:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/ledningen/</loc>
		<lastmod>2026-04-14T09:12:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/</loc>
		<lastmod>2026-04-16T07:53:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/company/governance/general-meeting/annual-general-meeting-2026/</loc>
		<lastmod>2026-04-16T13:25:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/foretaget/bolagsstyrning/bolagsstamma/arsstamma-2026/</loc>
		<lastmod>2026-04-16T13:29:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/anvandarvillkor/</loc>
		<lastmod>2026-04-23T15:00:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/privacy-notice/</loc>
		<lastmod>2026-04-24T08:47:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/sv/</loc>
		<lastmod>2026-04-28T15:32:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.io-ext.se/en/investors/the-share/ownership/</loc>
		<lastmod>2026-05-08T12:24:39+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->